Director Dealing

Calnex Solutions

26/11/2025 07:30

RNS Number : 9733I

Calnex Solutions PLC

26 November 2025

 

26 November 2025

Calnex Solutions plc

("Calnex" or the "Company")

Director Dealing

Calnex Solutions plc (AIM: CLX), an established provider of test and measurement solutions for the global telecommunications sector, confirms that on 25 November 2025 Helen Kelisky, Non-executive Director of the Company, purchased 20,000 ordinary shares in the Company at a price of 48.4 pence per share.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

 

1
Details of PDMR/person closely associated with them ("PCA")
1.1
Name
Helen Kelisky
1.2
Position/Status
Non-Executive Director
1.3
Initial notification / amendment
Initial notification
2
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
2.1
Name
Calnex Solutions plc
2.2
LEI
213800GY6TURGL3HYT04
3
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
3.1
Description of the financial instrument
Identification code
Ordinary shares of 0.125 pence each

 GB00BMBK7016
3.2
Nature of the transaction
Purchase of Ordinary Shares
3.3
Price(s) and volume(s)
Price(s)
Volume(s)
£.0.484
20,000
3.4
Aggregated information
· Aggregated volume
· Price
20,000
£9,691.95
3.5
Date of the transaction
25th November 2025
3.6
Place of the transaction
London Stock Exchange (AIM:CLX)

 

 

For more information, please contact:

Calnex Solutions plc
Via Alma PR
Tommy Cook, Chief Executive Officer
Ashleigh Greenan, Chief Financial Officer
Cavendish Capital Markets Limited - Nomad & Broker
+44 (0)131 220 6939
Derrick Lee / Peter Lynch
Alma PR
+ 44(0) 20 3405 0213
Caroline Forde, Hannah Campbell, Joe Pederzolli


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBLBDBUUDDGUU